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PTo Screen or Not to Screen?
Depression in Patients With Cardiovascular Disease
Mary A. Whooley, MD
San Francisco, California
There is considerable controversy about whether patients with cardiovascular disease should be screened for
depression. Depression is known to be associated with increased morbidity and mortality, but screening by itself
does not improve either depression or cardiovascular outcomes. Nonetheless, depression deserves treatment
regardless of its cardiovascular effects, and screening plus collaborative care is cost effective in primary care
settings. Thus, patients with cardiovascular disease should receive routine screening for depression by primary
care providers in the context of a collaborative care treatment program. (J Am Coll Cardiol 2009;54:891–3)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.05.034i
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phere is considerable controversy about whether screening
or depression should be part of standard care for patients
ith cardiovascular disease (CVD). A 2008 American Heart
ssociation (AHA) Science Advisory recommended routine
creening for depression in all patients with coronary heart
isease (1), but a subsequent systematic review concluded
here is no evidence that screening is of benefit (2). Others
ave suggested that screening for depression may benefit
atients, but only if performed in the context of a collabo-
ative care treatment model, including frequent follow-up
y a case manager and streamlined access to a mental health
rovider (3,4). Now, Ziegelstein et al. (5) say “Never mind,”
nd call for a reassessment of the AHA Science Advisory.
How do we make sense of all of this? Should patients
ith CVD be screened for depression? Will screening
mprove cardiovascular outcomes?
The 2008 AHA Science Advisory concluded that “De-
ression is commonly present in patients with coronary
eart disease and is independently associated with increased
ardiovascular morbidity and mortality. Therefore, screen-
ng tests for depressive symptoms should be applied to
dentify patients who may require further assessment and
reatment” (1). Given the overwhelming evidence that
epression is associated with adverse outcomes in patients
ith CVD, and the availability of easy-to-administer and
easonably accurate screening instruments (6), it is under-
tandable to think that screening for depression would
mprove outcomes. Indeed, our primary care colleagues
ame to this same conclusion 15 years ago when depression
ad been clearly linked with poor medical outcomes (7), and
rom the Veterans Affairs Medical Center and University of California, Sanc
rancisco, California.
Manuscript received May 2, 2009; accepted May 5, 2009.t was thought that screening and informing health care
roviders about depression would improve these outcomes.
Unfortunately, subsequent randomized controlled trials
ddressing this very question found little if any benefit from
creening for depression (8–11). Although screening re-
ulted in enhanced recognition and treatment, it did not
mprove depression because the majority of patients did
ot receive adequate dosage or duration of antidepressant
herapy. Nearly one-half of patients discontinued treat-
ent during the first month, and few received the
ecommended levels of follow-up care (12). Alas, it was
oncluded that “there is substantial evidence that rou-
inely administered screening questionnaires for depres-
ion have minimal impact on the detection, management
r outcome of depression” (13).
The question then became: what else is needed for
creening to be of benefit? Numerous randomized trials
ere conducted to determine whether screening for depres-
ion, in combination with a collaborative care intervention,
ould improve outcomes (14–21). These and other trials
ventually concluded that screening can improve depression,
ut only when combined with a collaborative care interven-
ion (3,4,22). There were also potential harms of screening,
ncluding perceived stigma from false-positive results and
iversion of health care resources from other needs. How-
ver, at least in primary care settings, these potential harms
eemed to be outweighed by the benefits of screening plus
ollaborative care (23).
What is collaborative care? Katon and Unutzer (23) have
dentified 2 essential elements: 1) a depression care manager
an allied health professional, preferably with a mental
ealth background) to educate patients, provide close
ollow-up, and monitor treatment adherence; and 2) a
sychiatrist to provide case load supervision for depression
are managers and clinical advice to primary care providers.
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Screening for Depression September 1, 2009:891–3Collaborative care interventions
typically take 3 to 6 months, and
many aspects of treatment can be
accomplished over the telephone
(4,24–26). Although collabora-
tive care programs can be associ-
ated with increased cost in the
short term (27), they are cost
ffective and probably cost saving in the longer term
28–30).
In theory, patients with CVD should be at least as
ikely as primary care patients to benefit from depression
creening in the context of a collaborative care treatment
rogram. However, only a few studies have specifically
valuated this in the cardiovascular care setting. Freed-
and et al. (31) screened patients for depression after
oronary artery bypass surgery and randomly assigned
hose with depression to cognitive behavioral therapy,
upportive stress management, or usual care. Participants
ho received cognitive behavioral therapy or supportive
are were more likely to achieve remission of depression
han those who received usual care. In the Bypassing the
lues Trial (32), patients were screened for depression
fter coronary artery bypass grafting, and those who
creened positive were randomly assigned to a collabora-
ive care treatment intervention versus usual care. This
tudy has recently been completed, and preliminary
esults are promising (33). Another multicenter random-
zed trial is currently evaluating the effect of a heart
ailure management program that includes screening plus
ollaborative care for depression on cardiovascular health
tatus (J. Rumsfeld, M. Sullivan, personal communica-
ion, April 2009).
Where does this leave current cardiovascular practice
ith regard to depression screening? To date, there is no
vidence that screening plus collaborative care improves
ardiovascular outcomes (2). Importantly, absence of
vidence does not equal evidence of absence, and there is
lso no evidence that screening plus collaborative care has
ny negative effects on cardiovascular outcomes. How-
ver, until we can demonstrate that screening plus col-
aborative care improves cardiovascular outcomes, the
esponsibility for screening will continue to remain with
he primary care provider.
Does this mean that cardiologists can ignore depres-
ion? Absolutely not. Depression is present in at least 1 in
patients with CVD and is associated with both poor
uality of life and adverse cardiovascular outcomes (34–36).
etails about case finding and treatment for depression
n patients with CVD have been described elsewhere
6). This simply means that routine screening of patients
ho are not otherwise suspected to have depression has
o proven benefit outside of a collaborative care treat-
ent program. When depression is recognized, the most
Abbreviations
and Acronyms
AHA  American Heart
Association
CVD  cardiovascular
diseasevidence-based approach is for the cardiologist to makeure that the patient is evaluated by a primary care
rovider who can offer collaborative care treatment.
Depression meets most criteria for screening (common
isease with significant morbidity, low cost and risk of
creening, effective therapy available), but whether early
etection and treatment improves cardiovascular outcomes
s unknown. What we do know is that depression deserves
reatment regardless of its cardiovascular effects, reasonable
creening tools are available, and screening plus collabora-
ive care is cost effective in primary care settings. Until we
re able to demonstrate that screening for depression im-
roves cardiovascular outcomes, patients with CVD should
e screened for depression by primary care providers in the
ontext of a collaborative care treatment program. The
ptimal frequency of depression screening will require
urther study.
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